Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 1
2020 3
2021 3
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
Bilbao A, Spanagel R. Bilbao A, et al. BMC Med. 2022 Aug 19;20(1):259. doi: 10.1186/s12916-022-02459-1. BMC Med. 2022. PMID: 35982439 Free PMC article. Review.
METHODS: We systematically reviewed (registered at PROSPERO: CRD42021229932) eight databases for randomized controlled trials (RCTs) of dronabinol, nabilone, cannabidiol and nabiximols for chronic pain, spasticity, nausea /vomiting, appetite, ALS, irritable bowel …
METHODS: We systematically reviewed (registered at PROSPERO: CRD42021229932) eight databases for randomized controlled trials (RCTs) of dron …
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's disease, Huntington's disease, Alzheimer's disease and multiple sclerosis, as well as anorexia and irritable bowel syndrome. A …
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's disease …
Cannabinoids and the Gastrointestinal Tract.
Camilleri M, Zheng T. Camilleri M, et al. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3217-3229. doi: 10.1016/j.cgh.2023.07.031. Epub 2023 Sep 9. Clin Gastroenterol Hepatol. 2023. PMID: 37678488 Review.
The CB(2)-receptor agonist, cannabidiol, reduced the total Gastroparesis Cardinal Symptom Index and increases the ability to tolerate a meal in patients with gastroparesis appraised over 4 weeks of treatment. In contrast, predominant-pain end points in functional dyspepsia …
The CB(2)-receptor agonist, cannabidiol, reduced the total Gastroparesis Cardinal Symptom Index and increases the ability to tolerate …
Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing.
van Orten-Luiten AB, de Roos NM, Majait S, Witteman BJM, Witkamp RF. van Orten-Luiten AB, et al. Cannabis Cannabinoid Res. 2022 Aug;7(4):436-444. doi: 10.1089/can.2020.0087. Epub 2021 Feb 11. Cannabis Cannabinoid Res. 2022. PMID: 33998882 Free PMC article. Clinical Trial.
Background: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders. ...Anecdotal reports and preclinical data suggest that the endocannabinoid system and functionally related mechanisms could offer treatment targets. Cannabidio …
Background: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders. ...Anecdotal reports a …
Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.
Uranga JA, Martínez V, Abalo R. Uranga JA, et al. Molecules. 2020 Sep 20;25(18):4314. doi: 10.3390/molecules25184314. Molecules. 2020. PMID: 32962285 Free PMC article. Review.
One important feature of mast cells is that their population is usually increased in animal models and biopsies from patients with irritable bowel syndrome (IBS). Therefore, mast cells and mast cell mediators are regarded as key components in IBS pathophysiol …
One important feature of mast cells is that their population is usually increased in animal models and biopsies from patients with irrita …
Cannabidiol and Intestinal Motility: a Systematic Review.
Story G, Briere CE, McClements DJ, Sela DA. Story G, et al. Curr Dev Nutr. 2023 Jul 17;7(10):101972. doi: 10.1016/j.cdnut.2023.101972. eCollection 2023 Oct. Curr Dev Nutr. 2023. PMID: 37786751 Free PMC article. Review.
Cannabidiol (CBD) is a non-intoxicating cannabinoid extracted from the cannabis plant that is used for medicinal purposes. ...
Cannabidiol (CBD) is a non-intoxicating cannabinoid extracted from the cannabis plant that is used for medicinal purposes. ...
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI, Nguyen LC, Oumeslakht L, Bensussan A, Ben Mkaddem S. Aziz AI, et al. Cannabis Cannabinoid Res. 2023 Apr;8(2):254-269. doi: 10.1089/can.2022.0133. Epub 2022 Nov 22. Cannabis Cannabinoid Res. 2023. PMID: 36413346 Review.
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in Cannabis extracts. ...Results: Findings suggest that CBD is a potent immunomodulatory drug as it has manifested immunosuppressive properties in the context of sterile inflammation (e.g., inflam …
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in Cannabis extracts. ...Results: Findings suggest that …
Top 20 Research Studies of 2022 for Primary Care Physicians.
Grad R, Ebell MH. Grad R, et al. Am Fam Physician. 2023 Apr;107(4):406-414. Am Fam Physician. 2023. PMID: 37054418
The American College of Gastroenterology updated its guideline for gastroesophageal reflux disease, and a new guideline provides sound advice for the evaluation and management of irritable bowel syndrome. Adults older than 60 years with prediabetes are more l …
The American College of Gastroenterology updated its guideline for gastroesophageal reflux disease, and a new guideline provides sound advic …
Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression.
Fan X, Shi J, Liu Y, Zhang M, Lu M, Qu D. Fan X, et al. Int J Nanomedicine. 2023 May 30;18:2839-2853. doi: 10.2147/IJN.S402871. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37273286 Free PMC article.
BACKGROUND: Berberine (BR) shows promise as a candidate for treating irritable bowel syndrome with diarrhea (IBS-D). However, the undesired physicochemical properties and poor oral absorption limit its clinical translation. ...METHODS: The microemulsions load …
BACKGROUND: Berberine (BR) shows promise as a candidate for treating irritable bowel syndrome with diarrhea (IBS-D). Ho …
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA, Muccioli GG, Ruggieri MR, Schicho R. Izzo AA, et al. Handb Exp Pharmacol. 2015;231:423-47. doi: 10.1007/978-3-319-20825-1_15. Handb Exp Pharmacol. 2015. PMID: 26408170 Review.
A pharmacological modulation of the endocannabinoid system might be beneficial for widespread diseases such as gastrointestinal reflux disease, irritable bowel syndrome, inflammatory bowel disease, colon cancer, cystitis, and hyperactive bladder. Drugs …
A pharmacological modulation of the endocannabinoid system might be beneficial for widespread diseases such as gastrointestinal reflux disea …
14 results